![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Dishman Pharma Approves Acquisition of UK Firm
Dishman Pharma Approves Acquisition of UK Firm
March 11, 2005
Dishman Pharmaceuticals & Chemicals Ltd has said that the board of directors of the company at its meeting has approved strategic acquisition of a UK-based contract research company through its 100 percent wholly owned subsidiary (WOS) company namely Dishman Europe. The Managing Director J R Vyas has been empowered to negotiate and finalize the terms of the acquisition and execute the necessary documents in this regard.
India Infoline (http://www.indiainfoline.com/news/news.asp?dat=55390)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct